Yamashita, et al. observed upregulated ARHGDIA levels in lymph node metastatic PCa patients and suggested that ARHGDIA may be useful as a diagnostic biomarker for PCa metastasis 23. Here, ARHGDIA is linked to posterior cortical atrophy.